Cambridge Investment Research Advisors, Inc. Care Dx, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$22.09 - $39.21 $1.87 Million - $3.31 Million	-84,481 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$19.89 - $30.02 $91,096 - $137,491	4,580 Added 5.73%	84,481 $2.12 Million
Q3 2018 Nov 02, 2018	SELL	$12.1 - $28.85 $94,948 - $226,385	-7,847 Reduced 8.94%	79,901 $0
Q2 2018 Aug 10, 2018	BUY	$7.93 - $15.79 $50,894 - $101,340	6,418 Added 7.89%	87,748 $0
Q1 2018 May 09, 2018	BUY	$5.18 - $7.97 $87,562 - $134,724	16,904 Added 26.24%	81,330 $0
Q4 2017 Feb 22, 2018	BUY	$3.98 - $7.37 $142,686 - $264,221	35,851 Added 125.46%	64,426 $0
Q3 2017 Nov 07, 2017	BUY	$1.33 - $4.12 $38,004 - $117,729	28,575	28,575 $106,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

Black Rock Inc. New York, NY

5.29M
Shares

$125 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.54M
Shares

$107 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.15M
Shares

$74.3 Million
1.65% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.99M
Shares

$70.6 Million
0.89% of portfolio
State Street Corp Boston, MA

2.04M
Shares

$48.1 Million
0.0% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.26B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account